Next-Generation Blood Culture Analysis System

Publication ID: 24-11857320_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Blood Culture Analysis System,” Published Technical Disclosure No. 24-11857320_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857320_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,320.

Summary of the Inventive Concept

A revolutionary system integrating blood sequestration devices with real-time analysis capabilities, enabling rapid diagnosis and targeted treatment of microbial infections.

Background and Problem Solved

The original patent's blood sequestration device, while effective, has limitations in terms of speed and accuracy of diagnosis. The present inventive concept addresses these limitations by incorporating advanced microfluidic and machine learning technologies to provide real-time blood culture analysis, enabling caregivers to respond promptly to microbial infections.

Detailed Description of the Inventive Concept

The next-generation blood culture analysis system comprises a microfluidic chip integrated with a blood sequestration device, which collects a blood sample and analyzes it in real-time using machine learning-based algorithms to identify microbial infections. The system can be configured as a wearable device, transmitting samples to a remote analysis center for diagnosis. Alternatively, the system can be implemented as a network of interconnected blood sequestration devices, providing a comprehensive view of a patient's blood health across multiple sampling sites. The system's advanced analytics enable personalized treatment recommendations based on a patient's genomic profile.

Novelty and Inventive Step

The integration of microfluidic and machine learning technologies with blood sequestration devices represents a significant departure from the original patent, providing a paradigm shift in blood culture analysis. The inventive concept's real-time analysis capabilities, wearable and networked configurations, and personalized treatment recommendations constitute novel and non-obvious advancements.

Alternative Embodiments and Variations

Alternative embodiments may include handheld or portable devices, implantable sensors, or cloud-based analysis platforms. Variations may involve different microfluidic chip designs, machine learning algorithms, or genomic profiling techniques.

Potential Commercial Applications and Market

The next-generation blood culture analysis system has vast commercial potential in the healthcare industry, particularly in hospitals, clinics, and remote patient monitoring settings. The system's ability to provide rapid and accurate diagnoses can significantly reduce healthcare costs and improve patient outcomes, making it an attractive solution for healthcare providers and patients alike.

Field of Art

Medical device engineering, specifically blood collection and diagnostic systems, with expertise in microfluidics, needle design, and medical instrumentation

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, working knowledge of blood collection technologies, microfluidic systems, and diagnostic instrumentation, familiar with emerging medical sensing and analysis techniques

Obviousness Rationale

A PHOSITA would recognize that integrating machine learning and microfluidic analysis with existing blood sequestration devices represents a predictable technological evolution. The source patent's fundamental blood collection mechanism provides a natural foundation for advanced diagnostic capabilities. The proposed variations leverage known technological trends in personalized medicine and real-time medical diagnostics.

Obvious Combinations & Variations

Source Patent Element
Blood sequestration device with retractable needle for controlled blood sample collection
PTD Variation
Integrating microfluidic chip for real-time blood analysis within the sequestration device
Obviousness Reasoning
Combining diagnostic capabilities with existing blood collection mechanisms is a known design approach in medical device engineering, representing a predictable technological enhancement
Source Patent Element
Needle manipulation mechanism with user-activated push tabs
PTD Variation
Implementing wireless connectivity and remote data transmission for collected samples
Obviousness Reasoning
Adding wireless communication to medical devices is a standard design choice with well-understood implementation techniques in the field of medical instrumentation
Source Patent Element
Blood sample isolation and collection method
PTD Variation
Developing networked blood sequestration devices for comprehensive patient monitoring
Obviousness Reasoning
Creating interconnected medical monitoring systems is a logical extension of existing device technologies, representing an obvious approach to improving diagnostic capabilities
Source Patent Element
Blood culture testing device
PTD Variation
Incorporating machine learning algorithms for automated infection detection
Obviousness Reasoning
Applying machine learning to medical diagnostic processes is a recognized trend, representing a predictable technological progression with well-understood implementation strategies
Source Patent Element
Blood sample collection mechanism
PTD Variation
Developing wearable, skin-conformable blood sequestration devices
Obviousness Reasoning
Miniaturization and wearable design of medical devices is a known technological trend, representing an obvious design evolution for improved patient monitoring
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857320 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed blood culture analysis system and associated methods obvious and anticipated, as the combination represents a predictable technological enhancement of existing blood sequestration device technologies through standard engineering design choices and known medical diagnostic techniques.

Original Patent Information

Patent NumberUS 11,857,320
TitleBlood sequestration device and method
Assignee(s)Smiths Medical ASD, Inc.